DM
AGIO icon

Deerfield Management’s Agios Pharmaceuticals AGIO Stock Holding History

Deerfield Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,658
Closed -$516K – 435
2024
Q1 		$516K Buy
+17,658
New +$473K 0.01% 136
2018
Q4 		– Sell
-348,200
Closed -$26.9M – 100
2018
Q3 		$26.9M Sell
348,200
-1,800
-0.5% -$145K 0.96% 39
2018
Q2 		$29.5M Sell
350,000
-16,000
-4% -$1.4M 1.04% 41
2018
Q1 		$29.9M Buy
366,000
+103,016
+39% +$7.96M 1.04% 34
2017
Q4 		$15M Buy
262,984
+54,984
+26% +$3.46M 0.59% 53
2017
Q3 		$13.9M Buy
+208,000
New +$12.5M 0.63% 52
2013
Q4 		– Sell
-151,050
Closed -$4.22M – 108
2013
Q3 		$4.22M Buy
+151,050
New +$4.17M 0.2% 84

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management's AGIO Position: Q2 2024 in Review

Deerfield Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2024, closing a stake of 17,658 shares — an estimated $516K sold.

Deerfield Management first reported a position in AGIO in Q3 2013 and held it in 7 quarters. The position peaked at $29.9M in Q1 2018. 205 funds tracked by Wall St. Rank hold AGIO as of Q2 2024.

  • Deerfield Management reported no remaining Agios Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Deerfield Management sold 17,658 Agios Pharmaceuticals shares in Q2 2024, an estimated $516K.
  • Deerfield Management first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Deerfield Management's Agios Pharmaceuticals position peaked at $29.9M in Q1 2018.
  • 205 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2024.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.